10X Genomics Inc
(TXG)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,223 | -39,774 | -22,603 | -11,551 | -542,731 |
| Depreciation Amortization | 28,254 | 20,930 | 13,655 | 6,468 | 19,021 |
| Accounts receivable | -34,041 | -27,216 | -7,824 | -6,189 | -17,847 |
| Accounts payable and accrued liabilities | 11,084 | 12,191 | 9,711 | 10,885 | -7,770 |
| Other Working Capital | -88,490 | -77,458 | -35,188 | -15,205 | -50,381 |
| Other Operating Activity | 120,043 | 84,149 | 41,287 | 11,510 | 381,810 |
| Operating Cash Flow | $-21,373 | $-27,178 | $-962 | $-4,082 | $-217,898 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -101,278 | -73,660 | -53,433 | -38,865 | -36,666 |
| Net Acquisitions | -5,451 | -5,451 | -5,451 | -5,451 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -1,728 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,728 |
| Investing Cash Flow | $-106,729 | $-79,111 | $-58,884 | $-44,316 | $-38,394 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,028 | -5,028 | -5,028 | -5,028 | -37,104 |
| Common Stock Issued | 40,325 | 31,422 | 24,739 | 8,546 | 506,010 |
| Financing Cash Flow | $35,297 | $26,394 | $19,711 | $3,518 | $468,906 |
| Exchange Rate Effect | 234 | 316 | 199 | 193 | -463 |
| Beginning Cash Position | 688,644 | 688,644 | 688,644 | 688,644 | 476,493 |
| End Cash Position | 596,073 | 609,065 | 648,708 | 643,957 | 688,644 |
| Net Cash Flow | $-92,571 | $-79,579 | $-39,936 | $-44,687 | $212,151 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,373 | -27,178 | -962 | -4,082 | -217,898 |
| Capital Expenditure | -101,278 | -73,660 | -53,433 | -38,865 | -36,666 |
| Free Cash Flow | -122,651 | -100,838 | -54,395 | -42,947 | -254,564 |